Financial Information

Consolidated Balance Sheet

Net Assets(¥ million)
		120th period	121th period
Settlement Date		March 2024	March 2025
Stockholders' Equity		40,219	41,477
Breakdown	Capital	5,451	5,451
	Capital Surplus	4,186	4,188
	Retained Earnings	31,233	32,480
	Treasury Stock	△652	△642
Accumulated Other Comprehensive Income		1,484	1,709
Breakdown	Valuation Difference on Other Securities	362	395
	Foreign Currency Translation Adjustment Account	81	203
	Accumulated Adjustment for Retirement Benefits	1,040	1,111
Total Net Assets		41,703	43,187
Total Liabilities and Net Assets		68,039	67,603

(¥ million)
	120th period	121th period
Month of settlement	March 2024	March 2025
Net sales	46,859	49,457
Cost of sales	32,988	34,555
Gross profit	13,871	14,902
Selling, general and administrative expenses	11,798	12,315
Other income	303	339
Other expenses	175	244
Ordinary income	2,201	2,681
Extraordinary income	71	-
Extraordinary loss	-	53
Income before income taxes	2,273	2,628
Corporate tax, etc	445	668
Net income	1,827	1,959
Net income attributable to non-controlling shareholders	-	-
Net income attributable to owners of parent	1,827	1,959

(¥ million)
	120th period	121th period
Month of settlement	March 2024	March 2025
Cash flows from operating activities	3,187	3,690
Cash flows from investing activities	△3,692	△1,695
Cash flows from financing activities	△1,225	△763
Exchange differences on cash and cash equivalents	27	25
Change in cash and cash equivalents	△1,702	1,257
Cash and cash equivalents at beginning of year	14,752	13,049
Cash and cash equivalents at end of year	13,049	14,307